Effect of nerodilol and carvone on in vitro permeation of nicorandil across rat epidermal membrane

Drug Development and Industrial Pharmacy

Volumn 32, Issue 4, 2006, Pages 423-435

  Krishnaiah, Yellela S R ^a   Al Saidan, Saleh M ^a   Chandrasekhar, Dantam V ^b   Rama, Bukka ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b ANDHRA UNIVERSITY   (India)

Author keywords

Carvone; In vitro permeation; Nerodilol; Nicorandil; Rat epidermal membrane

Indexed keywords

CALCIUM ANTAGONIST; CARVONE; HYDROXYPROPYLMETHYLCELLULOSE; LIMONENE; NERODILOL; NICORANDIL; TERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG PENETRATION; EPIDERMIS; GEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; NONHUMAN; RAT; SKIN PENETRATION; STRATUM CORNEUM;

ADMINISTRATION, CUTANEOUS; ANIMALS; EPIDERMIS; GELS; METHYLCELLULOSE; MODELS, BIOLOGICAL; MONOTERPENES; NICORANDIL; PERMEABILITY; RATS; SKIN ABSORPTION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TERPENES; VASODILATOR AGENTS;

EID: 33646470285     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040500528939     Document Type: Article

References (42)

1. Afouna, M. I., Fincher, T. K., Khan, M. A., & Reddy, I. K. (2003). Percutaneous permeation of enantiomers and racemates of chiral drugs and prediction of their flux ratios using thermal data: a pharmaceutical perspective. Chirality, 75, 456-465.
2. Al-Saidan, S. M., Krishnaiah, Y. S. R., Chandrasekhar, D. V., Lalla, J. K., Rama, B., Jayaram, B., & Bhaskar, P. (2004). Formulation of an HPMC gel drug reservoir system with ethanol-water as a solvent system and limonene as a penetration enhancer for enhancing in vitro transdermal delivery of nicorandil. Skin Pharmacol. Physiol., 17, 310-320.
3. Arellano, A., Santoyo, S., Martin, C., & Ygartua, P. (1996). Enhancing effect of terpene on the in vitro percutaneous absorption of diclofenac sodium. Int. J. Pharm., 130, 141-145.
4. Berner, B., Otte, J. H., Mazzenga, G. C., Steffens, R. J., & Ebert, C. D. (1989). Ethanol:water mutually enhanced transdermal therapeutic system. I: Nitroglycerin solution properties and membrane transport. J. Pharm. Sci., 78, 314-318.
5. Bhatia, K. S., Gao, S., & Singh, J. (1997). Effect of penetration enhancers and iontophoresis on the FT-IR spectrometry and LHRH permeability through porcine skin. J. Control. Release, 47, 81-89.
6. Bouwstra, J. A., Gooris, G. S., van der Spek, J. A., & Bras, W. (1991). Structural investigations of human stratum corneum by small-angle x-ray scattering. J. Invest. Dermatol., 97, 1005-1012.
7. Cal, K., Janicki, S., & Sznitowska, M. (2001). In vitro studies on penetration of terpenes from matrix-type transdermal systems through human skin. Int. J. Pharm., 224, 81-88.
8. Cornwell, P. A., Barry, B. W., Bouwstra, J. A., & Gooris, G. S. (1996). Modes of action of terpene penetration enhancers in human skin; differential scanning calorimetry, small-angle x-ray diffraction and enhancer uptake studies. Int. J. Pharm., 127, 9-26.
9. Cornwell, P. A., & Barry, B. W. (1991). Sequiterpoenes components of volatile oils as skin penetration enhncers for the hydrophilic permeant 5-fluorouracil. J Pharm. Pharmacol., 46, 261-269.
10. Cornwell, P. A., Barry, B. W., Stoddart, C. P., & Bouwstra, J. A. (1994). Wide-angle x-ray diffraction of human stratum corneum: effects of hydration and terpene enhancer treatment. J. Pharm. Pharmacol., 46, 938-950.
11. Diez, I., Colom, H., Moreno, J., Obach, R., Peraire, C., & Domenech, J. (1991). A comparative in vitro study of transdermal absorption of a series of calcium channel antagonists. J. Pharm. Sci., 80, 931-934.
12. Elias, P. M. (1996). The stratum corneum revisited. J. Dermatol., 23, 756-758.
13. El-Kattan, A. F., Asbill, C. S., Kim, N., & Michniak, B. B. (2001). The effects of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities. Int. J. Pharm., 215, 229-240.
14. El-Kattan, A. F., Asbill, C. S., & Michniak, B. B. (2000). The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems. Int. J. Pharm., 198, 179-189.
15. Frampton, J., Buckley, M. M., Fitton, A., & Nicorandil, (1992). A review of its pharmacology and therapeutic efficacy in angina pectoris. Drugs, 44, 625-655.
16. Frydman, A. (1992). Pharmacokinetic profile of nicorandil in humans: an overview. J. Cardiovasc. Pharmacol., 20(Suppl 3), S34-S44.
17. Gao, S., & Singh, J. (1998). In vitro percutaneous absorption enhancement of lipophilic drug tamoxifen by terpenes. J. Control. Release, 51, 193-199.
18. Goates, C. Y., & Knutson, K. (1994). Enhanced permeation of polar compounds through human epidermis. I. Permeability and membrane structural changes in the presence of short chain alcohols. Biochem. Biophys. Acta, 1195, 169-179.
19. Golden, G. M., Guzek, D. B., Harris, R. R., McKie, J. E., & Potts, R. O. (1986). Lipid thermotropic transitions in human stratum corneum. J. Invest. Dermatol., 86, 255-259.
20. Hori, M., Satoh, S., Maibach, H. I., & Guy, R. H. (1991). Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro: effect of enhancer lipophilicity. J. Pharm. Sci., 80, 32-35.
21. Kerins, D. M., Robertson, R. M., & Robertson, D. (2001). Drugs used for the treatment of myocardial ischemia. In Goodman & Gilman's The Pharmacological Basis of Therapeutics, (10th Ed.), Hardman, J. G., & Limbird, L. E., Eds.; New York: McGraw Hill Medical Publishing Division, p. 864.
22. Keshary, P. R., & Chien, Y. W. (1984). Mechanism of transdermal controlled nitroglycerin administration. Part 2. Assessment of rate controlling steps. Drug Dev. Ind. Pharm., 10, 1663-1699.
23. Krishnaiah, Y. S. R., Bhaskar, P., & Satyanarayana, V. (2003). Effect of carvone on the permeation of nimodipine from membrane-moderated transdermal therapeutic system. Pharmazie, 58, 559-563.
24. Krishnaiah, Y. S. R., Satyanarayana, V., & Bhaskar, P. (2003). Formulation and in vivo evaluation of membrane-moderated transdermal therapeutic systems of nicardipine hydrochloride using carvone as a penetration enhancer. Drug Deliv, 10, 101-109.
25. Kurihara-Bergstrom, T., Knutson, K., De Noble, L. J., & Goates, C.Y. (1990). Percutaneous absorption enhancement of an ionic molecule by ethanol-water systems in human skin. Pharm. Res., 7, 762-766.
26. Leonard, T. W., Mikula, K. K., & Schlesinger, M. S. (1989). Carvone enhancement of transdermal drug delivery. U.S. Patent 4888360.
27. Megrab, N. A., Williams, A. C., & Barry, B. W. (1995). Oestradiol permeation across human skin, silastic, and snake skin membranes: the effects of ethanol/water co-solvent systems. Int. J. Pharm., 116, 101-112.
28. Moffat, A. C., Osselton, M. D., & Widdop, B. (2004). In Clarke's Analysis of Drugs and Poisons in Pharmaceuticals, Body Fluids, and Postmortem Materials. London: Pharmaceutical Press, 1332-1333.
29. Moghimi, H. R., Williams, A. C., & Barry, B. W. (1997). Lamellar matrix model for stratum corneum intercellular lipids. Part 5. Effects of terpene penetration enhancers on the structure and thermal behavior of the matrix. Int. J. Pharm., 146, 41-54.
30. Morimoto, H., Wada, Y., Seki, T., & Sugibayashi, K. (2002). In vitro skin permeation of morphine hydrochloride during the finite application of penetration-enhancing system containing water, ethanol, and L-menthol. Biol. Pharm. Bull., 15, 134-136.
31. Okabe, H., Takayama, K., Ogura, A., & Nagai, T. (1989). Effect of limonene and related compounds on the percutaneous absorption of indomethacin. Drug Des. Deliv., 4, 313-321.
32. Okamoto, H., Hashida, M., & Sezaki, H. (1988). Structure-activity relationship of 1-alkyl- or 1-alkenylazacycloalkanone derivatives as percutaneous penetration enhancers. J. Pharm. Sci., 77, 418-424.
33. Pershing, L. K., Lambert, L. D., & Knutson, K. (1990). Mechanism of ethanol-enhanced estradiol permeation across human skin in vivo. Pharm. Res., 7, 170-175.
34. Prausnitz, M. R., Mitragotri, S., & Langer, R. (2004). Current status and future potential of transdermal drug delivery. Nat. Rev. Drug Discovery., 3, 115-124.
35. Sato, K., Sugibayashi, K., Morimoto, Y., Omiya, H., & Enomoto, N. (1989). Prediction of the in vitro human skin permeability of nicorandil from animal data. J. Pharm. Pharmacol., 41, 379-383.
36. Sato, K., Sugibayashi, K., & Morimoto, Y. (1991). Species differences in percutaneous absorption of nicorandil. J. Pharm. Sci., 80, 104-107.
37. Takahashi, K., Sakano, H., Yoshida, M., Numata, N., & Mizuno, N. (2001). Characterization of the influences of polyol fatty acid esters on the permeation of diclofenac through rat skin. J. Control. Release, 73, 351-358.
38. Tipre, D. N., & Vavia, P. R. (2002). Formulation optimization and stability study of transdermal therapeutic system of nicorandil. Pharm. Dev. Technol., 7, 325-332.
39. Williams, A. C., & Barry, B. W. (2004). Penetration enhancers. Adv. Drug Deliv. Rev., 56, 603-618.
40. Yum, S., Lee, E., Taskovich, L., & Theeuwes, F. (1994). Permeation enhancement with ethanol: Mechanism of action through skin. In Drug Permeation Enhancement, Hsich, D. S., Ed.; New York: Marcel Dekker Inc., 143-170.
41. Zhao, K., & Singh, J. (1999). In vitro percutaneous absorption enhancement of propranolol hydrochloride through porcine epidermis by terpenes/ethanol. J Control. Release, 62, 359-366.
42. Zhao, K., & Singh, J. (1998). Mechanisms of percutaneous absorption of tamoxifen by terpenes: eugenol, D-limonene and menthone. J. Control. Release, 55, 253-260.